(MENAFN- GlobeNewsWire - Nasdaq) Opportunities span biologics, biosimilars, generics and aseptic processing, driven by single-use systems, advanced membranes, automation, IoT monitoring and local sourcing.Dublin, Sept. 14, 2026 (GLOBE NEWSWIRE) -- "Pharmaceutical Filtration Market Report 2026" has been added to ResearchAndMarkets.com's offering.
Pharmaceutical Filtration Market to Reach $10.01 Billion by 2030 as Demand for Sterile Manufacturing Grows
The global pharmaceutical filtration market is projected to grow from $7.65 billion in 2025 to $8.07 billion in 2026, representing a compound annual growth rate (CAGR) of 5.6%. Historical market growth has been supported by stringent regulatory requirements, expanding pharmaceutical manufacturing activity, rising demand for sterile products, advances in filtration technologies and continued investment in biopharmaceutical production facilities.
Looking ahead, the pharmaceutical filtration market is forecast to reach $10.01 billion by 2030, expanding at a CAGR of 5.5%. Growth during the forecast period is expected to be driven by the increasing production of biologics and biosimilars, wider adoption of single-use filtration systems, integration of automation and smart manufacturing technologies, higher investment in aseptic processing and the need to maintain contamination-free pharmaceutical production environments.
Key pharmaceutical filtration market trends include the development of advanced filtration membranes, increased use of disposable and single-use systems, and the integration of Internet of Things technologies into filtration monitoring. Automated filtration processes are also gaining traction as manufacturers seek to strengthen process control, increase production efficiency and maintain consistent product quality. In addition, demand for high-purity water and air filtration is rising as pharmaceutical and biopharmaceutical producers expand their sterile manufacturing capabilities.
The growing demand for generic medicines is expected to provide further momentum for pharmaceutical filtration market growth. Filtration systems are essential to generic drug manufacturing because they remove particulate contaminants from liquids and gases while supporting product purity and regulatory compliance. In July 2025, the U.S. Food and Drug Administration reported that the availability of generic medicines generated more than $400 billion in savings for the U.S. healthcare system. Continued demand for affordable medicines is therefore expected to increase pharmaceutical production volumes and support investment in reliable filtration equipment and processes.
Strategic collaborations are helping market participants improve downstream purification methods for exosome production. In January 2023, RoosterBio Inc. announced a collaboration with Sartorius AG focused on developing an exosome manufacturing platform using human mesenchymal stem and stromal cells. The initiative is intended to improve potency, purity and yield while advancing analytical methods for the characterization of exosomes and other extracellular vesicles.
The RoosterBio and Sartorius collaboration also supports the development of quantitative quality-control strategies for exosome purification and final drug products. Scalable filtration platforms, including Sartoflow Smart and Sartoflow Advanced equipment, are expected to help improve product clarity, concentration and formulation. Such partnerships demonstrate the growing importance of scalable pharmaceutical filtration solutions in advanced therapy and biopharmaceutical manufacturing.
Merger and acquisition activity is also strengthening the competitive position of filtration technology providers. In May 2023, Xylem Inc. acquired Evoqua Water Technologies for $7.5 billion. The acquisition expanded Xylem's portfolio and enhanced its ability to address demand for sustainable water treatment and pharmaceutical filtration solutions. It also strengthened the company's operational capabilities and market presence amid rising requirements for high-purity water across pharmaceutical production facilities.
North America was the largest region in the pharmaceutical filtration market in 2025. The geographic regions covered by the market include Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. Countries covered include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, the United Kingdom, the United States, Canada, Italy and Spain.
Markets Covered:
1) By Product: Membrane Filters; Prefilters And Depth Media; Single-Use Systems; Cartridges And Capsules; Filter Holders; Filtration Accessories; Other Products
2) By Technique: Microfiltration; Ultrafiltration; Crossflow Filtration; Nanofiltration; Other Techniques
3) By Scale Of Operation: Manufacturing Scale; Pilot-Scale; Research And Development Scale
4) By Application: Final Product Processing; Raw Material Filtration; Bioburden Testing; Cell Separation; Water Purification; Air Purification
Subsegments:
1) By Membrane Filters: Microfiltration Filters; Ultrafiltration Filters; Nanofiltration Filters; Reverse Osmosis Filters
2) By Prefilters And Depth Media: Depth Filters; Prefilters for Membrane Systems
3) By Single-Use Systems: Single-Use Filtration Devices; Disposable Filter Assemblies
4) By Cartridges And Capsules: Filter Cartridges; Filter Capsules
5) By Filter Holders: Laboratory Filter Holders; Industrial Filter Holders
6) By Filtration Accessories: Connectors; Housings; Validation Equipment
7) By Other Products: Specialized Filters; Custom Filtration Solutions
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Key Attributes:
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood,Senior Press Manager...
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Comments
No comment